Neuralink shows first brain-chip patient playing online chess – ET HealthWorld

Neuralink shows first brain-chip patient playing online chess – ET HealthWorld

E lon Musk’s brain-chip startup Neuralink livestreamed on Wednesday its first patient implanted with a chip playing online chess. Noland Arbaugh, the 29-year-old patient who was paralyzed below the shoulder after a diving accident, was playing chess on his laptop and moving the cursor using the Neuralink device. He had received an implant from the … Read more

Official action indicated for Biocon arm’s unit in Malaysia after USFDA inspection

Official action indicated for Biocon arm’s unit in Malaysia after USFDA inspection

Representational image only. | Photo Credit: The Hindu Biocon Limited on October 18 said the U.S. health regulator has classified as ‘official action indicated’ for the manufacturing facility of group firm Biocon Sdn Bhd at Johor, Malaysia following an inspection. The OAI (Official Action Indicated) status may cause delay and/or withholding of pending product approvals … Read more

USFDA pulls up Sun Pharma for lapses in its Gujarat plant

USFDA pulls up Sun Pharma for lapses in its Gujarat plant

In a warning letter, the US Food and Drug Administration pointed out various lapses at the Halol plant which produces finished pharmaceutical products. | Photo Credit: Special Arrangement The U.S. health regulator has pulled up drug major Sun Pharma for manufacturing lapses, including failure to follow appropriate written procedures designed to prevent microbiological contamination of … Read more

Wysa receives USFDA approval for AI led device for mental health – ET HealthWorld

Wysa receives USFDA approval for AI led device for mental health – ET HealthWorld

Bangalore: Wysa, an artificial intelligence (AI)-based platform for behavioural health, has announced that the United States Food and Drug Administration (FDA) has granted breakthrough device designation for its AI-based digital mental health conversational agent for patients 18 years and older with a diagnosis of chronic musculoskeletal pain, depression and anxiety. The device delivers cognitive behavioural … Read more

US: FDA backs Pfizer COVID-19 boosters for seniors, high-risk

photo

The US moved a step closer Wednesday to offering booster doses of ‘s COVID-19 vaccine to senior citizens and others at high risk from the virus as the Food and Drug Administration signed off on the targeted use of extra shots. The FDA authorized booster doses for Americans who are 65 and older, younger adults … Read more

Zydus Cadila gets USFDA nod for arthritis drug with 180-days exclusivity – ET HealthWorld

zydus cadila gets usfda nod for arthritis drug with 180 days

New Delhi: Drug firm Zydus Cadila on Monday said it has received final approval from the US health regulator to market Tofacitinib extended-release tablets, used to treat rheumatoid arthritis, in the American market. The company said it has received approval from the US Food and Drug Administration (USFDA) for the drug in 11 mg and … Read more

DCGI approved QR 678 formulation proves to be a differentiator from traditional hair transplant treatment

QR678 Vial

The QR 678 ® therapy has also demonstrated encouraging results in post chemotherapy induced hair loss, treatment of hair conditions like seborrheic dermatitis and in immunogenic diseases like alopecia areata. By Dr. Debraj Shome Drugs Controller General of India (DCGI) approved QR 678 has bridged the gap in the hair regrowth market and has proven … Read more

Evrysdi has ushered a new journey of hope for patients living with SMA in India: V Simpson Emmanuel

Roche Evrysdi 1

Evrysdi is a disease modifying therapy that has to be taken for life. Globally, 60% of kids born with Spinal Muscular Atrophy (SMA) every year suffer from SMA Type 1. 68% of the children with type 1 SMA die before their second birthday and 82% of the children with type 1 SMA die before their … Read more

It’s time India’s drug controller confronts key questions on quality control & enforcement

covid 19 drugs

At a larger level, the drug regulator needs to address some fundamental challenges with the Indian drug regulatory system. (Representational image: IE) If the pandemic, its two waves and unending variants with their sub-lineages have left many in pain, the spreading plague of unethical human behaviour and fraudulent business practices has left many unnerved over … Read more

The week that was in 10 stocks: RIL, Adani Green Energy shine, BDL plunges

photo

NEW DELHI: Benchmark indices registered gains of one-and-a-half per cent during a week that saw tech stocks in the US plunging sharply but spectacular performance by Reliance Industries kept the market buoyant. Among the outperformers of this week, most names belonged to the internet, pharma and technology sectors while PSU sectors and multiplexes were among … Read more